An alloresponse in humans is dominated by cytotoxic T lymphocytes (CTL) cross-reactive with a single Epstein-Barr virus CTL epitope: implications for graft-versus-host disease

doi:10.1084/jem.179.4.1155

This Article

	Full Text (PDF)
	Alert me when this article is cited
	Citation Map

Services

	Email this article
	Similar articles in this journal
	Similar articles in PubMed
	Alert me to new content in the JEM
	Download to citation manager

Citing Articles

	Citing Articles via HighWire
	Citing Articles via CrossRef
	Citing Articles via Google Scholar

Google Scholar

	Articles by Burrows, S. R.
	Articles by Moss, D. J.
	Search for Related Content

PubMed

	PubMed Citation
	Articles by Burrows, S. R.
	Articles by Moss, D. J.


Social Bookmarking

	What's this?

ARTICLES

An alloresponse in humans is dominated by cytotoxic T lymphocytes (CTL) cross-reactive with a single Epstein-Barr virus CTL epitope: implications for graft-versus-host disease

SR Burrows, R Khanna, JM Burrows and DJ Moss
Queensland Institute of Medical Research, Bancroft Centre, Herston, Brisbane, Australia.

The phenomenon of T cell allorecognition is difficult to accommodate within the framework of a T cell repertoire positively selected in the thymus, unless allorecognition results from the cross-reactions of self- major histocompatibility complex restricted T cells. Herein, we demonstrate the dual specificity of cytotoxic T lymphocyte (CTL) clones for the immunodominant Epstein-Barr virus (EBV) epitope FLRGRAYGL, presented on HLA-B8, and the alloantigen HLA-B*4402. CTL which recognized peptide FLRGRAYGL in association with HLA-B8 could be reactivated in vitro from healthy individuals who had been exposed previously to EBV, using stimulator cells expressing the cross-reacting alloantigen HLA-B*4402. Limiting dilution analysis of the alloresponse to HLA-B*4402 in eight healthy individuals revealed that HLA-B8+, EBV- sero+ donors had higher CTL precursor frequencies for alloantigen HLA- B*4402 than EBV-sero- control donors. It is surprising that the majority (65-100%) of anti-HLA-B*4402 CTL, generated in limiting dilution mixed lymphocyte reactions between responder cells from HLA- B8+, EBV-sero+ individuals and HLA-B*4402+ stimulators, also recognized the EBV CTL epitope FLRGRAYGL/HLA-B8. In contrast to previous studies showing extensive diversity in the T cell repertoire against individual alloantigens, these data demonstrate that the response to an alloantigen can be dominated by CTL cross-reactive with a single viral epitope, thus illustrating a possible mechanism for the frequent clinical association between herpesvirus exposure and graft-versus-host disease after bone marrow transplants.
Add to CiteULike CiteULike Add to Complore Complore Add to Connotea Connotea Add to Del.icio.us Del.icio.us Add to Digg Digg Add to Reddit Reddit Add to Technorati Technorati What's this?

This article has been cited by other articles:

Stapler, D., Lee, E. D., Selvaraj, S. A., Evans, A. G., Kean, L. S., Speck, S. H., Larsen, C. P., Gangappa, S. (2008). Expansion of Effector Memory TCR V{beta}4+CD8+ T Cells Is Associated with Latent Infection-Mediated Resistance to Transplantation Tolerance. J. Immunol. 180: 3190-3200 [Abstract] [Full Text]
Sloan, D. D., Jerome, K. R. (2007). Herpes Simplex Virus Remodels T-Cell Receptor Signaling, Resulting in p38-Dependent Selective Synthesis of Interleukin-10. J. Virol. 81: 12504-12514 [Abstract] [Full Text]
Selin, L. K., Brehm, M. A. (2007). Frontiers in Nephrology: Heterologous Immunity, T Cell Cross-Reactivity, and Alloreactivity. J. Am. Soc. Nephrol. 18: 2268-2277 [Abstract] [Full Text]
Archbold, J. K., Macdonald, W. A., Miles, J. J., Brennan, R. M., Kjer-Nielsen, L., McCluskey, J., Burrows, S. R., Rossjohn, J. (2006). Alloreactivity between Disparate Cognate and Allogeneic pMHC-I Complexes Is the Result of Highly Focused, Peptide-dependent Structural Mimicry. J. Biol. Chem. 281: 34324-34332 [Abstract] [Full Text]
Landais, E., Morice, A., Long, H. M., Haigh, T. A., Charreau, B., Bonneville, M., Taylor, G. S., Houssaint, E. (2006). EBV-Specific CD4+ T Cell Clones Exhibit Vigorous Allogeneic Responses. J. Immunol. 177: 1427-1433 [Abstract] [Full Text]
Kasprowicz, V., Isa, A., Jeffery, K., Broliden, K., Tolfvenstam, T., Klenerman, P., Bowness, P. (2006). A Highly Restricted T-Cell Receptor Dominates the CD8+ T-Cell Response to Parvovirus B19 Infection in HLA-A*2402-Positive Individuals.. J. Virol. 80: 6697-6701 [Abstract] [Full Text]
Koehn, B., Gangappa, S., Miller, J. D., Ahmed, R., Larsen, C. P. (2006). Patients, pathogens, and protective immunity: the relevance of virus-induced alloreactivity in transplantation.. J. Immunol. 176: 2691-2696 [Abstract] [Full Text]
Brehm, M. A., Daniels, K. A., Ortaldo, J. R., Welsh, R. M. (2005). Rapid Conversion of Effector Mechanisms from NK to T Cells during Virus-Induced Lysis of Allogeneic Implants In Vivo. J. Immunol. 174: 6663-6671 [Abstract] [Full Text]
Ely, L. K., Green, K. J., Beddoe, T., Clements, C. S., Miles, J. J., Bottomley, S. P., Zernich, D., Kjer-Nielsen, L., Purcell, A. W., McCluskey, J., Rossjohn, J., Burrows, S. R. (2005). Antagonism of Antiviral and Allogeneic Activity of a Human Public CTL Clonotype by a Single Altered Peptide Ligand: Implications for Allograft Rejection. J. Immunol. 174: 5593-5601 [Abstract] [Full Text]
Elkington, R., Khanna, R. (2005). Cross-recognition of human alloantigen by cytomegalovirus glycoprotein-specific CD4+ cytotoxic T lymphocytes: implications for graft-versus-host disease. Blood 105: 1362-1364 [Abstract] [Full Text]
Meyer-Olson, D., Shoukry, N. H., Brady, K. W., Kim, H., Olson, D. P., Hartman, K., Shintani, A. K., Walker, C. M., Kalams, S. A. (2004). Limited T Cell Receptor Diversity of HCV-specific T Cell Responses Is Associated with CTL Escape. J. Exp. Med. 200: 307-319 [Abstract] [Full Text]
Sloan, D. D., Zahariadis, G., Posavad, C. M., Pate, N. T., Kussick, S. J., Jerome, K. R. (2003). CTL Are Inactivated by Herpes Simplex Virus-Infected Cells Expressing a Viral Protein Kinase. J. Immunol. 171: 6733-6741 [Abstract] [Full Text]
Macdonald, W. A., Purcell, A. W., Mifsud, N. A., Ely, L. K., Williams, D. S., Chang, L., Gorman, J. J., Clements, C. S., Kjer-Nielsen, L., Koelle, D. M., Burrows, S. R., Tait, B. D., Holdsworth, R., Brooks, A. G., Lovrecz, G. O., Lu, L., Rossjohn, J., McCluskey, J. (2003). A Naturally Selected Dimorphism within the HLA-B44 Supertype Alters Class I Structure, Peptide Repertoire, and T Cell Recognition. J. Exp. Med. 198: 679-691 [Abstract] [Full Text]
Lakkis, F. G., Sayegh, M. H. (2003). Memory T Cells: A Hurdle to Immunologic Tolerance. J. Am. Soc. Nephrol. 14: 2402-2410 [Full Text]
Burrows, S. R., Elkington, R. A., Miles, J. J., Green, K. J., Walker, S., Haryana, S. M., Moss, D. J., Dunckley, H., Burrows, J. M., Khanna, R. (2003). Promiscuous CTL Recognition of Viral Epitopes on Multiple Human Leukocyte Antigens: Biological Validation of the Proposed HLA A24 Supertype. J. Immunol. 171: 1407-1412 [Abstract] [Full Text]
Brehm, M. A., Markees, T. G., Daniels, K. A., Greiner, D. L., Rossini, A. A., Welsh, R. M. (2003). Direct Visualization of Cross-Reactive Effector and Memory Allo-Specific CD8 T Cells Generated in Response to Viral Infections. J. Immunol. 170: 4077-4086 [Abstract] [Full Text]
Kjer-Nielsen, L., Clements, C. S., Brooks, A. G., Purcell, A. W., Fontes, M. R., McCluskey, J., Rossjohn, J. (2002). The Structure of HLA-B8 Complexed to an Immunodominant Viral Determinant: Peptide-Induced Conformational Changes and a Mode of MHC Class I Dimerization. J. Immunol. 169: 5153-5160 [Abstract] [Full Text]
Peacock, C. D., Lin, M. Y., Ortaldo, J. R., Welsh, R. M. (2000). The Virus-Specific and Allospecific Cytotoxic T-Lymphocyte Response to Lymphocytic Choriomeningitis Virus Is Modified in a Subpopulation of CD8+ T Cells Coexpressing the Inhibitory Major Histocompatibility Complex Class I Receptor Ly49G2. J. Virol. 74: 7032-7038 [Abstract] [Full Text]
Bingaman, A. W., Ha, J., Waitze, S.-Y., Durham, M. M., Cho, H. R., Tucker-Burden, C., Hendrix, R., Cowan, S. R., Pearson, T. C., Larsen, C. P. (2000). Vigorous Allograft Rejection in the Absence of Danger. J. Immunol. 164: 3065-3071 [Abstract] [Full Text]
Welsh, R. M., Markees, T. G., Woda, B. A., Daniels, K. A., Brehm, M. A., Mordes, J. P., Greiner, D. L., Rossini, A. A. (2000). Virus-Induced Abrogation of Transplantation Tolerance Induced by Donor-Specific Transfusion and Anti-CD154 Antibody. J. Virol. 74: 2210-2218 [Abstract] [Full Text]
Gustafsson, A., Levitsky, V., Zou, J.-Z., Frisan, T., Dalianis, T., Ljungman, P., Ringden, O., Winiarski, J., Ernberg, I., Masucci, M. G. (2000). Epstein-Barr virus (EBV) load in bone marrow transplant recipients at risk to develop posttransplant lymphoproliferative disease: prophylactic infusion of EBV-specific cytotoxic T cells. Blood 95: 807-814 [Abstract] [Full Text]
Weekes, M. P., Wills, M. R., Mynard, K., Carmichael, A. J., Sissons, J. G.�P. (1999). The Memory Cytotoxic T-Lymphocyte (CTL) Response to Human Cytomegalovirus Infection Contains Individual Peptide-Specific CTL Clones That Have Undergone Extensive Expansion In Vivo. J. Virol. 73: 2099-2108 [Abstract] [Full Text]
Tan, L. C., Gudgeon, N., Annels, N. E., Hansasuta, P., O'Callaghan, C. A., Rowland-Jones, S., McMichael, A. J., Rickinson, A. B., Callan, M. F. C. (1999). A Re-Evaluation of the Frequency of CD8+ T Cells Specific for EBV in Healthy Virus Carriers. J. Immunol. 162: 1827-1835 [Abstract] [Full Text]
Burrows, S. R., Khanna, R., Moss, D. J. (1999). Direct Alloreactivity by Human Cytotoxic T Lymphocytes Can Be Inhibited by Altered Peptide Ligand Antagonism. Blood 93: 1020-1024 [Abstract] [Full Text]